← All Repligen CORP filings

Repligen CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
RGEN
Repligen CORP
DEF: Repligen 2026 Proxy Statement Summary
Repligen Corporation has released its 2026 Proxy Statement detailing the upcoming Annual Meeting, director elections, and executive compensation.
NASDAQ
RGEN
Repligen CORP
DEFA14A: Repligen Corporation: Upcoming Annual Meeting and Proxy Statement Overview
Repligen Corporation announces its 2025 Annual Meeting of Stockholders and provides details on voting for key proposals.
NASDAQ
RGEN
Repligen CORP
DEF: Repligen Corporation Announces 2025 Annual Meeting and Proxy Statement
Repligen Corporation releases its 2025 proxy statement, outlining key proposals for the upcoming annual meeting, including director elections, auditor ratification, executive compensation, and a liability amendment.
NASDAQ
RGEN
Repligen CORP
DEFA14A: Repligen Corrects Proxy Statement Regarding Executive Equity Acceleration
Repligen issues a supplement to its proxy statement clarifying that certain executive equity awards are subject to double-trigger, not single-trigger, acceleration upon a change in control.
NASDAQ
RGEN
Repligen CORP
DEFA14A: Repligen Corporation Sets Date for Annual Meeting, Outlines Proposals for Stockholder Vote
Repligen Corporation's upcoming annual meeting on May 16, 2024, will include voting on the election of directors, ratification of Ernst & Young LLP as the independent accounting firm, and an advisory vote on executive compensation.
NASDAQ
RGEN
Repligen CORP
DEF 14A: Repligen Corporation Announces 2024 Annual Meeting of Shareholders, Outlines Executive Compensation and Governance Practices
Repligen Corporation's proxy statement details the agenda for the 2024 annual shareholder meeting, director nominees, executive compensation, and corporate governance highlights.